Nubain and Back pain aggravated - a phase IV clinical study of FDA data

Summary:

Back pain aggravated is reported as a side effect among people who take Nubain (nalbuphine hydrochloride), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Toradol, and have Headache.

The phase IV clinical study analyzes which people have Back pain aggravated when taking Nubain. It is created by eHealthMe based on reports of 1,718 people who have side effects when taking Nubain from the FDA, and is updated regularly.

What is Nubain?

Nubain has active ingredients of nalbuphine hydrochloride. It is often used in pain. eHealthMe is studying from 1,749 Nubain users. Check the latest studies of Nubain.

What is Back pain aggravated?

Back pain aggravated is found to be associated with 3,360 drugs and 2,098 conditions by eHealthMe. Check the latest studies of Back pain aggravated.

On Aug, 05, 2026

1,718 people reported to have side effects when taking Nubain.
Among them, 36 people (2.1%) have Back pain aggravated.

Could Nubain cause Back pain aggravated?

Among these 36 people:

How long have people been on Nubain when they have Back pain aggravated? *

What is the gender of people who have Back pain aggravated when taking Nubain? *

female: 80 %
male: 20 %

What is the age of people who have Back pain aggravated when taking Nubain? *

What are other drugs people take besides Nubain? *

What are other side effects people have besides Back pain aggravated? *

Fatigue (feeling of tiredness): 14 people, 38.89%
Head Injury: 12 people, 33.33%
Joint Pain: 12 people, 33.33%
Fall: 12 people, 33.33%
Weight Increased: 11 people, 30.56%
Fever: 10 people, 27.78%
Nausea (feeling of having an urge to vomit): 10 people, 27.78%
Pain In Extremity: 9 people, 25.00%
Hypoaesthesia (reduced sense of touch or sensation): 9 people, 25.00%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 9 people, 25.00%

What are the existing conditions these people have? *

Headache (pain in head): 6 people, 16.67%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 8.33%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 2.78%
Neuropathy Peripheral (surface nerve damage): 1 person, 2.78%
Nervousness: 1 person, 2.78%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.78%
Multiple Myeloma (cancer of the plasma cells): 1 person, 2.78%
Migraine (headache): 1 person, 2.78%
Micturition Disorder (disease of passing urine): 1 person, 2.78%
Induced Labor: 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Nubain and have Back pain aggravated?

- Check whether Back pain aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nubain:

Nubain (1,749 reports)

Browse all side effects of Nubain:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Back pain aggravated:

Back pain aggravated (3,360 drugs)

Browse all the conditions that are associated with Back pain aggravated:

Back pain aggravated (2,098 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nalbuphine hydrochloride (the active ingredients of Nubain) and Nubain (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.